Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -30.39% is 96% above its 5-year average of -705.91%, near the high end of its 5-year range (-2025.55%–-15.62%).
89.55% above its 12-month average of -290.89%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -341.40%.
OPERATING MARGIN
-30.39%
OPERATING MARGIN AVG TTM
-290.89%
OPERATING MARGIN AVG 3Y
-521.72%
OPERATING MARGIN AVG 5Y
-705.91%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+89.55%
CURRENT VS 3Y AVG
+94.18%
CURRENT VS 5Y AVG
+95.69%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Pulsenmore Ltd. Ordinary Shares
Market Cap
$14.24M
Operating Margin
-30.39%
TTM Avg
-290.89%
3Y Avg
-521.72%
5Y Avg
-705.91%
Market Cap
$13.99M
Operating Margin
-1053.14%
TTM Avg
-1090.26%
3Y Avg
-1143.76%
5Y Avg
-1293.19%
Market Cap
$14.11M
Operating Margin
-859.22%
TTM Avg
-477.88%
3Y Avg
-341.34%
5Y Avg
-316.87%
Market Cap
$13.84M
Operating Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.36M
Operating Margin
-1062.29%
TTM Avg
-1250.55%
3Y Avg
-3518.84%
5Y Avg
-2345.89%
Market Cap
$15.03M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-4987.62%
Market Cap
$13.18M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$13.08M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulsenmore Ltd. Ordinary Shares (PLSM) | $14.24M | -30.39% | -290.89% | -521.72% | -705.91% |
| Sintx Technologies, Inc. (SINT)vs › | $13.99M | -1053.14% | -1090.26% | -1143.76% | -1293.19% |
| Vyome Holdings, Inc. (HIND)vs › | $14.11M | -859.22% | -477.88% | -341.34% | -316.87% |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.84M | N/A | N/A | N/A | N/A |
| Optimi Health Corp. (OPTH)vs › | $13.36M | -1062.29% | -1250.55% | -3518.84% | -2345.89% |
| IN8bio, Inc. (INAB)vs › | $13.33M | 0.00% | 0.00% | 0.00% | 0.00% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.03M | 0.00% | 0.00% | 0.00% | -4987.62% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.18M | 0.00% | 0.00% | 0.00% | 0.00% |
| Passage Bio, Inc. (PASG)vs › | $13.08M | 0.00% | 0.00% | 0.00% | 0.00% |
| Jin Medical International Ltd. (ZJYL)vs › | $15.03M | 2.94% | 9.21% | 11.00% | 11.87% |
Gross Margin
84.2%
Operating Margin
-30.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -341.40% |
| 2025-12-31 | -15.62% |
| 2025-06-30 | -515.65% |
| 2024-12-31 | -417.34% |
| 2024-06-30 | -460.92% |
| 2023-12-31 | -707.03% |
| 2023-06-30 | -1194.07% |
| 2022-12-31 | -368.15% |
| 2022-06-30 | -558.69% |
| 2021-12-31 | -1160.57% |
| 2021-06-30 | -2025.55% |
